Recurrence free survival. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy3

Cell Line, Tumor Lymph Nodes Cells, Cultured

Organisms1

Mice, Inbred C57BL

Diseases49

Neoplasm Recurrence, Local Recurrence Breast Neoplasms Lymphatic Metastasis Neoplasm Metastasis Liver Neoplasms Lung Neoplasms Adenocarcinoma Disease Progression Neoplasm Invasiveness Carcinoma, Hepatocellular Colorectal Neoplasms Carcinoma, Squamous Cell Brain Neoplasms Carcinoma, Non-Small-Cell Lung Bone Neoplasms Carcinoma Sarcoma Urinary Bladder Neoplasms Ovarian Neoplasms Prostatic Neoplasms Postoperative Complications Carcinoma, Ductal, Breast Head and Neck Neoplasms Neoplasm, Residual Stomach Neoplasms Nasopharyngeal Neoplasms Hodgkin Disease Glioblastoma Neoplasms, Glandular and Epithelial Pancreatic Neoplasms Kidney Neoplasms Carcinoma, Renal Cell Gastrointestinal Neoplasms Lymphoma, Non-Hodgkin Rectal Neoplasms Precursor Cell Lymphoblastic Leukemia-Lymphoma Multiple Myeloma Uterine Cervical Neoplasms Melanoma Soft Tissue Neoplasms Skin Neoplasms Neoplasms Atrial Fibrillation Neoplasm Seeding Colonic Neoplasms Carcinoma, Transitional Cell Disease Models, Animal Osteosarcoma

Chemicals and Drugs39

Tumor Markers, Biological Antineoplastic Agents Fluorouracil Cisplatin Cyclophosphamide Free Radicals Vincristine Doxorubicin Receptors, Estrogen Receptor, erbB-2 Receptors, Progesterone Ki-67 Antigen Methotrexate Etoposide Prednisone Deoxycytidine Carboplatin Organoplatinum Compounds Antineoplastic Agents, Alkylating Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Leucovorin Antineoplastic Agents, Hormonal Tamoxifen Neoplasm Proteins Paclitaxel Antibodies, Monoclonal Ifosfamide Taxoids RNA, Messenger Antibodies, Monoclonal, Murine-Derived Receptor, Epidermal Growth Factor Antineoplastic Agents, Phytogenic Cytarabine Protein Kinase Inhibitors Angiogenesis Inhibitors Prostate-Specific Antigen Free Radical Scavengers Immunosuppressive Agents

Analytical, Diagnostic and Therapeutic Techniques and Equipment71

Disease-Free Survival Prognosis Neoplasm Staging Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Proportional Hazards Models Chemotherapy, Adjuvant Radiotherapy, Adjuvant Prospective Studies Multivariate Analysis Immunohistochemistry Risk Factors Neoplasm Grading Predictive Value of Tests Cohort Studies Neoadjuvant Therapy Radiotherapy Dosage Drug Administration Schedule Risk Assessment Chemoradiotherapy Radiotherapy Lymph Node Excision Remission Induction Salvage Therapy Prostatectomy Dose Fractionation Brachytherapy Liver Transplantation Tumor Burden Immunoenzyme Techniques Tissue Array Analysis Radiotherapy, Intensity-Modulated Randomized Controlled Trials as Topic Clinical Trials as Topic Registries Chi-Square Distribution Radiotherapy, Conformal Transplantation, Autologous Transplantation, Homologous Gene Expression Profiling Risk Reverse Transcriptase Polymerase Chain Reaction Hepatectomy Reoperation Catheter Ablation Tomography, X-Ray Computed Hematopoietic Stem Cell Transplantation Incidence Actuarial Analysis Mastectomy, Segmental Peripheral Blood Stem Cell Transplantation Mastectomy Probability Treatment Failure Analysis of Variance Life Tables Kidney Transplantation Curettage Biopsy Surgical Mesh Postoperative Period Disease Models, Animal Preoperative Care Gastrectomy Cryosurgery

Phenomena and Processes14

Cell Survival Time Factors Graft Survival Gene Expression Regulation, Neoplastic Apoptosis Cell Proliferation Chi-Square Distribution Mutation Risk Dose-Response Relationship, Drug Drug Resistance, Neoplasm Signal Transduction Probability Graft Rejection

Disciplines and Occupations1

Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena1

Information Science6

Survival Rate Radiotherapy, Intensity-Modulated Registries Radiotherapy, Conformal Incidence Life Tables

Health Care28

Disease-Free Survival Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Kaplan-Meier Estimate Proportional Hazards Models Prospective Studies Multivariate Analysis Risk Factors Predictive Value of Tests Cohort Studies Risk Assessment Age Factors Randomized Controlled Trials as Topic Clinical Trials as Topic Registries Chi-Square Distribution Risk Incidence Actuarial Analysis Probability Treatment Failure Analysis of Variance Life Tables Postoperative Period Preoperative Care

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Health Care Geographicals

Neoplasm Recurrence, Local Disease-Free Survival Prognosis Neoplasm Staging Recurrence Treatment Outcome Survival Analysis Survival Rate Retrospective Studies Follow-Up Studies Breast Neoplasms Cell Survival Kaplan-Meier Estimate Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Time Factors Survival Tumor Markers, Biological Proportional Hazards Models Graft Survival Chemotherapy, Adjuvant Lymphatic Metastasis Radiotherapy, Adjuvant Neoplasm Metastasis Liver Neoplasms Prospective Studies Multivariate Analysis Lung Neoplasms Immunohistochemistry Antineoplastic Agents Risk Factors Neoplasm Grading Adenocarcinoma Disease Progression Predictive Value of Tests Neoplasm Invasiveness Fluorouracil Carcinoma, Hepatocellular Cohort Studies Colorectal Neoplasms Cisplatin Carcinoma, Squamous Cell Neoadjuvant Therapy Brain Neoplasms Cyclophosphamide Radiotherapy Dosage Carcinoma, Non-Small-Cell Lung Free Radicals Vincristine Bone Neoplasms Carcinoma Doxorubicin Sarcoma Drug Administration Schedule Receptors, Estrogen Urinary Bladder Neoplasms Risk Assessment Receptor, erbB-2 Chemoradiotherapy Ovarian Neoplasms Prostatic Neoplasms Gene Expression Regulation, Neoplastic Radiotherapy Lymph Node Excision Remission Induction Postoperative Complications Salvage Therapy Age Factors Receptors, Progesterone Cell Line, Tumor Ki-67 Antigen Prostatectomy Methotrexate Dose Fractionation Etoposide Carcinoma, Ductal, Breast Prednisone Brachytherapy Liver Transplantation Deoxycytidine Carboplatin Apoptosis Head and Neck Neoplasms Tumor Burden Organoplatinum Compounds Immunoenzyme Techniques Neoplasm, Residual Stomach Neoplasms Lymph Nodes Cell Proliferation Antineoplastic Agents, Alkylating Nasopharyngeal Neoplasms Antibodies, Monoclonal, Humanized Antimetabolites, Antineoplastic Leucovorin Tissue Array Analysis Radiotherapy, Intensity-Modulated Hodgkin Disease Randomized Controlled Trials as Topic Glioblastoma

No FAQ available that match "recurrence free survival"